Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Development Services for Next Generation Biopharmaceuticals

Please log in for more information

 

Paragon Gene Therapy, a unit of Catalent Biologics, provides industry-leading process development and cGMP manufacturing services for next generation biopharmaceuticals such as gene therapies, next-generation vaccines, and oncolytic immunotherapies. Specializing in scalable adeno-associated virus (AAV) platforms across multiple serotypes, Paragon Gene Therapy has several clinical through commercial production facilities in the Greater Maryland area, totalling over 400,000 square feet of space, all in close-proximity to leading universities and government research institutions.

Since 2016, Paragon Gene Therapy has produced more than 100 clinical cGMP batches across 40 programs with many of the leading gene therapy developers worldwide.

More Information

Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Company Information

Company name: Catalent Pharma Solutions

Address: 14 Schoolhouse Road, Somerset, NJ 08873, United States of America

Phone: +1-888-SOLUTION (USA) / 00800 88 55 6178 (Europe/RoW)

Email: solutions@catalent.com

Visit Website

Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

With 85 years’ experience across prescription and consumer markets, Catalent has the deepest expertise, the broadest offerings, and the most innovative technologies, to help its customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and supply.

From a single, tailored solution, to multiple answers throughout a product’s lifecycle, Catalent can improve the total value of treatments, and accelerate programs to clinic and beyond.

Related White Papers

It's a matter of taste!

| Contributed by GalenIQ

Investigating the Effects of Excipients on the Earliest Stages of Aggregation - Aggregation Inhibition by Arginine

| Contributed by Malvern Panalytical

Generic Nasal Spray Design

| Contributed by Malvern Panalytical

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register